Pharmaceutical - Financial

Filter

Current filters:

Financial

Popular Filters

1 to 25 of 1106 results

Mood lifts for Medtech in first half of 2014, while Pharma sector faces new struggles

Mood lifts for Medtech in first half of 2014, while Pharma sector faces new struggles

20-08-2014

An M&A frenzy that accounted for nearly $90 billion of equity set the pace for the first half of 2014…

FinancialGlobalJonathan GardnerMergers & AcquisitionsPharmaceutical

Novo Nordisk accepts fine from Danish public prosecutor over financial disclosure

Novo Nordisk accepts fine from Danish public prosecutor over financial disclosure

18-08-2014

Danish insulin giant Novo Nordisk has accepted a fine of 500,000 kroner ($89,735), imposed by the Public…

CopenhagenDanish Financial Supervisory AuthorityDenmarkDiabetesFinancialNovo NordiskPharmaceutical

New Zealand to fund Vidaza and Revlimid

New Zealand to fund Vidaza and Revlimid

13-08-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC says it has approved a proposal for funding…

Celgene Corp.FinancialHealthcareNew ZealandPharmaceuticalPricingRevlimidVidaza

Strong growth forecast for Saudi Arabia pharmaceuticals market

Strong growth forecast for Saudi Arabia pharmaceuticals market

13-08-2014

Pharmaceuticals products sales in Saudi Arabia are expected to exceed a value of $ 7 billion by 2018,…

Business FinanceFinancialMarkets & MarketingPharmaceuticalProductionRest of the WorldSaudi Arabia

ALK Abello reports strong improvement in 2nd-qtr financials

ALK Abello reports strong improvement in 2nd-qtr financials

13-08-2014

Denmark-based allergy specialist ALK Abello has reported significant progress in its sales for the second…

ALK AbelloDenmarkFinanceFinancialNorwegian kronePharmaceuticalRespiratory and Pulmonary

Merck KGaA 2nd-qtr earnings beat expectations

Merck KGaA 2nd-qtr earnings beat expectations

13-08-2014

German pharmaceuticals and chemicals major Merck KGaA said this morning that it has generated organic…

Business FinanceFinancialGermanyMerck KGaAMerck SeronoPharmaceutical

Boehringer Ingelheim sees 1st-half sales fall, but overcomes challenges

Boehringer Ingelheim sees 1st-half sales fall, but overcomes challenges

12-08-2014

German family-owned pharma major Boehringer Ingelheim reported first-half 2014 results, showing that…

Boehringer IngelheimChronic obstructive pulmonary disease therapyFinancialGermanyPharmaceutical

US federal drug discount program “faces challenges as it expands”

US federal drug discount program “faces challenges as it expands”

12-08-2014

A federal program that provides billions in drug discounts to safety net hospitals and other health care…

FinancialHealthHealth Medical PharmaHealthcarePharmaceuticalPharmaceutical industryPharmacologyRANDRegulationUSA

Prosensa and CureDuchenne expand DMD collaboration with $7 million funding boost

Prosensa and CureDuchenne expand DMD collaboration with $7 million funding boost

12-08-2014

Dutch biotech company Prosensa will receive a 5 million euros ($7 million) funding boost from US non-profit…

Duchenne Muscular DystrophyFinancialNetherlandsPharmaceuticalProsensaRare diseasesResearchUSA

US court orders SIGA to pay PharmAthene lump sum expectation damages

US court orders SIGA to pay PharmAthene lump sum expectation damages

11-08-2014

USA-based biodefense company PharmAthene says that, on Friday, the Delaware Court of Chancery issued…

Anti-viralsDelaware Court of ChanceryFinancialLegalPharmaceuticalPharmAtheneSIGA TechnologiesTecovirimatUSA

Multiple sclerosis treatments funding proposal in New Zealand

Multiple sclerosis treatments funding proposal in New Zealand

07-08-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC is seeking feedback on a funding proposal involving…

Biogen IdecFinancialGilenyaNeurologicalNew ZealandNovartisPharmaceuticalTysabri

Novo Nordisk beats estimates as net profit grows 4%

Novo Nordisk beats estimates as net profit grows 4%

07-08-2014

Danish diabetes care giant Novo Nordisk released first-half 2014 financial results this morning, showing…

Business FinanceChief executiveDiabetesFinancialNOKNovo NordiskPeptide hormonesPharmaceuticalRecombinant proteins

Allergan attacks Valeant’s financial results

Allergan attacks Valeant’s financial results

06-08-2014

US Botox maker Allergan, the subject of a hostile $53 billion takeover attempt by Canada’s Valeant…

AllerganBusiness FinanceCanadaFinancialMergers & AcquisitionsPharmaceuticalUSAValeant PharmaceuticalsValeant Pharmaceuticals International

EXPERT VIEW: How can pharmaceutical companies adapt to the digital era?

EXPERT VIEW: How can pharmaceutical companies adapt to the digital era?

06-08-2014

‘Digital pharma’ is by no means a new concept for pharmaceutical marketers. But what is new is that…

FinancialGlobalMarkets & MarketingPharmaceutical

Actavis reports 2nd-qtr revenues increase by over a third

Actavis reports 2nd-qtr revenues increase by over a third

05-08-2014

Ireland-headquartered generics major Actavis has reported a 34% boost in revenue in the second quarter…

ActavisActavis PharmaBusiness FinanceBusiness FinanceFinancialIrelandPharmaceutical

Australian exports of medicine fell by 13.5% in 2013-2014

Australian exports of medicine fell by 13.5% in 2013-2014

05-08-2014

Exports of medicine from Australia fell by 13.5% in 2013-2014, the lowest level since 2005-2006, and…

AustraliaBusiness FinanceFinancialManufacturing exportersManufacturing sectorPharmaceutical

Private equity firms could be looking to acquire mature GSK and Sanofi brands

Private equity firms could be looking to acquire mature GSK and Sanofi brands

05-08-2014

Private equity groups KKR and Warburg Pincus are considering a $10 billion plan to buy drug brands from…

Business FinanceFinancialGlaxoSmithKlineGlobalMylanPharmaceuticalSanofi

Vernalis achieves research milestones in Servier oncology collaborations

Vernalis achieves research milestones in Servier oncology collaborations

04-08-2014

UK biopharmaceutical company Vernalis and Servier, France’s largest independent drugmaker, say that…

FinanceFinancialFranceIan GarlandOncologyPharmaceuticalResearchServierUKVernalis

Biota tanks as flu drug candidate disappoints

Biota tanks as flu drug candidate disappoints

04-08-2014

USA-based Biota Pharmaceuticals saw its shares slump 29% to a record low of $2.29 on Friday, after the…

Anti-viralsAntibiotics and Infectious diseasesBiota PharmaceuticalsFinancialPharmaceuticalResearchUSA

UCB reports solid 1st-half performance

UCB reports solid 1st-half performance

31-07-2014

Belgian drugmaker UCB posted first-half 2014 revenue of 1.76 billion euros ($2.36 billion), plus 6%,…

BelgiumChemistryChief executiveEURFinancialOrganic chemistryPharmaceuticalUCBVimpat

US seniors save more than $11.5 billion on Rx drugs since 2010

US seniors save more than $11.5 billion on Rx drugs since 2010

31-07-2014

Information released by the US Department of Health and Human Services shows that more than 8.2 million…

FinancialHealthcareMedicarePharmaceuticalUSA

1 to 25 of 1106 results

Back to top